Manufacturer
AstraZeneca Pharmaceuticals
Pharmaceutical manufacturer based in United Kingdom
United Kingdom
- Products listed
- 74
- Molecules
- 30
- Therapy areas
- 11
AstraZeneca Pharmaceuticals is a pharmaceutical manufacturer based in United Kingdom. MedsAcross lists 74 of its products across 30 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United Kingdom
- Indian manufacturer
- No
- Also listed as
- AstraZeneca Pharmaceuticals LP
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply AstraZeneca Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
19 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Calquence 100 mg capsuleOral | Acalabrutinib | US FDA | Available on request |
| Calquence 100 mg tabletOral | Acalabrutinib | US FDA | Available on request |
| Etcamah 75 mg tabletOral | Camizestrant | US FDA | Available on request |
| Faslodex 250 mg/5 mL injectionIntramuscular Cold chain | Fulvestrant | US FDA | Available on request |
| Imfinzi 120 mg/2.4 mL injectionIntravenous Cold chain | Durvalumab | US FDA | Available on request |
| Imfinzi 500 mg/10 mL injectionIntravenous Cold chain | Durvalumab | US FDA | Available on request |
| Imjudo 25 mg/1.25 mL injectionIntravenous Cold chain | Tremelimumab | US FDA | Available on request |
| Imjudo 300 mg/15 mL injectionIntravenous Cold chain | Tremelimumab | US FDA | Available on request |
| Iressa 250 mg tabletOral | Gefitinib | US FDA | Available on request |
| Koselugo 10 mg capsuleOral Cold chain | Selumetinib | US FDA | Available on request |
| Koselugo 25 mg capsuleOral Cold chain | Selumetinib | US FDA | Available on request |
| Koselugo 5 mg granulesOral Cold chain | Selumetinib | US FDA | Available on request |
| Koselugo 7.5 mg granulesOral Cold chain | Selumetinib | US FDA | Available on request |
| Lynparza 100 mg tabletOral | Olaparib | US FDA | Available on request |
| Lynparza 150 mg tabletOral | Olaparib | US FDA | Available on request |
| Tagrisso 40 mg tabletOral | Osimertinib | US FDA | Available on request |
| Tagrisso 80 mg tabletOral | Osimertinib | US FDA | Available on request |
| Truqap 160 mg tabletOral | Capivasertib | US FDA | Available on request |
| Truqap 200 mg tabletOral | Capivasertib | US FDA | Available on request |
Respiratory
11 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Budesonide and Formoterol 160 mcg/4.5 mcg inhalerInhalationGeneric name | Budesonide and Formoterol | US FDA | Available on request |
| Budesonide and Formoterol 80 mcg/4.5 mcg inhalerInhalationGeneric name | Budesonide and Formoterol | US FDA | Available on request |
| Daliresp 250 mcg tabletOral | Roflumilast | US FDA | Available on request |
| Daliresp 500 mcg tabletOral | Roflumilast | US FDA | Available on request |
| Fasenra 10 mg/0.5 mL injectionSubcutaneous Cold chain | Benralizumab | US FDA | Available on request |
| Fasenra 30 mg/1 mL injectionSubcutaneous Cold chain | Benralizumab | US FDA | Available on request |
| Pulmicort Respules 0.25 mg/2 mL inhalation suspensionInhalation | Budesonide | US FDA | Available on request |
| Pulmicort Respules 0.5 mg/2 mL inhalation suspensionInhalation | Budesonide | US FDA | Available on request |
| Pulmicort Respules 1 mg/2 mL inhalation suspensionInhalation | Budesonide | US FDA | Available on request |
| Symbicort 160 mcg/4.5 mcg inhalerInhalation | Budesonide and Formoterol | US FDA | Available on request |
| Symbicort 80 mcg/4.5 mcg inhalerInhalation | Budesonide and Formoterol | US FDA | Available on request |
Psychiatry
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Seroquel 100 mg tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel 200 mg tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel 25 mg tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel 300 mg tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel 50 mg tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel XR 150 mg extended-release tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel XR 200 mg extended-release tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel XR 300 mg extended-release tabletOral | Quetiapine | US FDA | Available on request |
| Seroquel XR 400 mg extended-release tabletOral | Quetiapine | US FDA | Available on request |
Gastroenterology
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Nexium 10 mg delayed-release granulesOral | Esomeprazole | US FDA | Available on request |
| Nexium 2.5 mg delayed-release granulesOral | Esomeprazole | US FDA | Available on request |
| Nexium 20 mg delayed-release granulesOral | Esomeprazole | US FDA | Available on request |
| Nexium 20 mg delayed-release capsuleOral | Esomeprazole | US FDA | Available on request |
| Nexium 40 mg delayed-release granulesOral | Esomeprazole | US FDA | Available on request |
| Nexium 40 mg delayed-release capsuleOral | Esomeprazole | US FDA | Available on request |
| Nexium 5 mg delayed-release granulesOral | Esomeprazole | US FDA | Available on request |
Diabetes
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Byetta 300 mcg/1.2 mL injectionSubcutaneous Cold chain | Exenatide | US FDA | Available on request |
| Byetta 600 mcg/2.4 mL injectionSubcutaneous Cold chain | Exenatide | US FDA | Available on request |
| SymlinPen 1500 mcg/1.5 mL injectionSubcutaneous Cold chain | Pramlintide | US FDA | Available on request |
| SymlinPen 2700 mcg/2.7 mL injectionSubcutaneous Cold chain | Pramlintide | US FDA | Available on request |
Cardiology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Crestor 10 mg tabletOral | Rosuvastatin | US FDA | Available on request |
| Crestor 20 mg tabletOral | Rosuvastatin | US FDA | Available on request |
| Crestor 40 mg tabletOral | Rosuvastatin | US FDA | Available on request |
| Crestor 5 mg tabletOral | Rosuvastatin | US FDA | Available on request |
Haematology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Brilinta 60 mg tabletOral | Ticagrelor | US FDA | Available on request |
| Brilinta 90 mg tabletOral | Ticagrelor | US FDA | Available on request |
Immunology and transplant
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Saphnelo 120 mg/0.8 mL injectionSubcutaneous Cold chain | Anifrolumab | US FDA | Available on request |
| Saphnelo 300 mg/2 mL injectionIntravenous Cold chain | Anifrolumab | US FDA | Available on request |
Antidotes
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Andexxa 200 mg/20 mL powder for injectionIntravenous Cold chain | Andexanet alfa | US FDA | Available on request |
Nephrology and urology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lokelma 10 g/10 g powder for oral suspensionOral | Sodium zirconium cyclosilicate | US FDA | Available on request |
Neurology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Wainua 45 mg/0.8 mL injectionSubcutaneous Cold chain | Eplontersen | US FDA | Available on request |
Other products
13 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Airsupra 90 mcg/80 mcg inhalerInhalation | Albuterol and Budesonide | US FDA | Available on request |
| Baxfendy 1 mg tabletOral | Baxdrostat | US FDA | Available on request |
| Baxfendy 2 mg tabletOral | Baxdrostat | US FDA | Available on request |
| Bevespi Aerosphere 4.8 mcg/9 mcg inhalerInhalation | Formoterol and Glycopyrrolate | US FDA | Available on request |
| Breztri 160 mcg/4.8 mcg/18 mcg inhalerInhalation | Budesonide, Formoterol and Glycopyrrolate | US FDA | Available on request |
| Breztri 160 mcg/4.8 mcg/9 mcg inhalerInhalation | Budesonide, Formoterol and Glycopyrrolate | US FDA | Available on request |
| Farxiga 10 mg tabletOral | Dapagliflozin propanediol | US FDA | Available on request |
| Farxiga 5 mg tabletOral | Dapagliflozin propanediol | US FDA | Available on request |
| Xigduo XR 10 mg/1000 mg extended-release tabletOral | Dapagliflozin propanediol and Metformin | US FDA | Available on request |
| Xigduo XR 10 mg/500 mg extended-release tabletOral | Dapagliflozin propanediol and Metformin | US FDA | Available on request |
| Xigduo XR 2.5 mg/1000 mg extended-release tabletOral | Dapagliflozin propanediol and Metformin | US FDA | Available on request |
| Xigduo XR 5 mg/1000 mg extended-release tabletOral | Dapagliflozin propanediol and Metformin | US FDA | Available on request |
| Xigduo XR 5 mg/500 mg extended-release tabletOral | Dapagliflozin propanediol and Metformin | US FDA | Available on request |
Molecules made
Albuterol and BudesonideAndexanet alfaBaxdrostatFormoterol and GlycopyrrolateBudesonide, Formoterol and GlycopyrrolateTicagrelorBudesonide and FormoterolExenatideAcalabrutinibRosuvastatinRoflumilastCamizestrantDapagliflozin propanediolBenralizumabFulvestrantDurvalumabTremelimumabGefitinibSelumetinibSodium zirconium cyclosilicateOlaparibEsomeprazoleBudesonideAnifrolumabQuetiapinePramlintideOsimertinibCapivasertibEplontersenDapagliflozin propanediol and Metformin
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from AstraZeneca Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.